Newsroom
Sorted by: Latest
-
Samenvatting: Mosaic Therapeutics benoemt Dr Vince O'Neill, MD, tot Hoofd R&D
CAMBRIDGE, Engeland--(BUSINESS WIRE)--Mosaic Therapeutics, Ltd, (‘Mosaic’, of ‘het Bedrijf’), een bedrijf gespecialiseerd in oncologietherapeutica in klinische fase dat Synergistic Precision combinatietherapieën van de nieuwe generatie ontwikkelt, kondigde vandaag de benoeming aan van Dr Vince O’Neill tot Hoofd Research & Development (R&D) om de volgende groeifase van het bedrijf te ondersteunen. “We zijn opgetogen om Vince in het bestuursteam van Mosaic te mogen verwelkomen in deze cru...
-
SecurityTech on the Rise: G+D Reports Strong Order Intake and High Resilience in 2025
MUNICH--(BUSINESS WIRE)--In fiscal year 2025, Giesecke+Devrient (G+D) reaffirmed its position as global leader in SecurityTech for mission-critical infrastructure. In a market where security is becoming essential for technological and societal stability, G+D demonstrates strong growth prospects. In 2025, G+D achieved a record order intake of €3.6 billion (+8%). Revenue increased to €3.2 billion (+1%), although exchange rate effects dampened growth. The key figures underscore the company's stron...
-
Mosaic Therapeutics ernennt Dr Vince O'Neill, MD, zum Head of R&D
CAMBRIDGE, England--(BUSINESS WIRE)--Mosaic Therapeutics, Ltd, ('Mosaic’ oder ‘das Unternehmen’) ist ein Unternehmen für onkologische Therapeutika im klinischen Stadium, das Kombinationstherapien der kommenden Generation entwickelt. Heute hat Mosaic die Ernennung von Dr Vince O’Neill zum Head of Research and Development (R&D) bekannt gegeben, um die nächste Wachstumsphase zu unterstützen. „Wir freuen uns, in einer entscheidenden Entwicklungsphase des Unternehmens Vince im Führungsteam von M...
-
Riassunto: Mosaic Therapeutics nomina il Dr. Vince O'Neill, MD, Responsabile di R&S
CAMBRIDGE, Inghilterra--(BUSINESS WIRE)--Mosaic Therapeutics, Ltd, ("Mosaic", o "la Società") azienda specializzata in farmaci oncologici in fase clinica che sviluppano terapie di combinazione Synergistic Precision di nuova generazione, oggi ha reso nota la nomina del Dr. Vince O’Neill a Responsabile di Ricerca e Sviluppo (R&S) per supportare la sua nuova fase di crescita. “Siamo entusiasti di accogliere Vince al team dirigente di Mosaic in questa fase critica dell'evoluzione dell'azienda”,...
-
Resumen: Mosaic Therapeutics nombra al Dr. Vince O'Neill, médico, director de I+D
CAMBRIDGE, Inglaterra--(BUSINESS WIRE)--Mosaic Therapeutics, Ltd. («Mosaic» o «la empresa»), una empresa de terapias oncológicas en fase clínica dedicada al desarrollo de terapias combinadas de precisión sinérgicas de última generación, ha anunciado hoy el nombramiento del Dr. Vince O’Neill como director de Investigación y Desarrollo (I+D) para respaldar su próxima fase de crecimiento. «Nos complace dar la bienvenida a Vince al equipo directivo de Mosaic en esta etapa importante de la evolución...
-
Mosaic Therapeutics nomme Vince O’Neill au poste de directeur de la R&D
CAMBRIDGE, Angleterre--(BUSINESS WIRE)--Mosaic Therapeutics, Ltd (« Mosaic » ou « la société »), une société de thérapies oncologiques au stade clinique développant des thérapies combinées de précision synergiques de nouvelle génération, a annoncé aujourd’hui la nomination de Vince O’Neill au poste de directeur de la recherche et du développement (R&D) afin de soutenir sa prochaine phase de croissance. « Nous sommes ravis d’accueillir Vince au sein de l’équipe de direction de Mosaic à cette...
-
TotalEnergies et Masdar créent une coentreprise d’une valeur de 2,2 milliards de dollars pour accélérer la croissance des énergies renouvelables en Asie
PARIS & ABOU DHABI, Émirats arabes unis--(BUSINESS WIRE)--TotalEnergies (Paris:TTE) (LSE:TTE) (NYSE:TTE), major multi‑énergies intégrée, et Abu Dhabi Future Energy Company PJSC – Masdar, leader mondial des énergies renouvelables, ont signé un accord pour créer une coentreprise détenue à parts égales (50/50), d’une valeur de 2,2 milliards de dollars, qui regroupera leurs activités renouvelables terrestres dans neuf pays d’Asie. Alors que la demande d’électricité accélère en Asie, ce partenariat...
-
TotalEnergies and Masdar to Form $2.2 Billion Joint Venture to Accelerate Renewable Energy Growth in Asia
PARIS & ABU DHABI, United Arab Emirates--(BUSINESS WIRE)--TotalEnergies (Paris:TTE) (LSE:TTE) (NYSE:TTE), a global integrated multi‑energy company, and Abu Dhabi Future Energy Company PJSC – Masdar, a global clean energy leader, have signed a binding agreement to establish a $2.2bn 50/50 joint venture (JV) that will merge their onshore renewable activities in nine countries across Asia. As electricity demand accelerates across Asia, this partnership brings together capital and expertise to deli...
-
TotalEnergies SE UK Regulatory Announcement: TotalEnergies and Masdar to Form $2.2 Billion Joint Venture to Accelerate Renewable Energy Growth in Asia
PARIS--(BUSINESS WIRE)-- TotalEnergies (Paris:TTE) (LSE:TTE) (NYSE:TTE), a global integrated multi‑energy company, and Abu Dhabi Future Energy Company PJSC – Masdar, a global clean energy leader, have signed a binding agreement to establish a $2.2bn 50/50 joint venture (JV) that will merge their onshore renewable activities in nine countries across Asia. As electricity demand accelerates across Asia, this partnership brings together capital and expertise to deliver renewable energy at the scal...
-
Bona Releases 2025 Sustainability Report
MALMÖ, Sweden--(BUSINESS WIRE)--Bona®, a global, family-owned company that supplies products for installing, renovating, maintaining, and restoring premium floors, has published its 2025 Sustainability Report. The report outlines progress across Bona’s three sustainability pillars – Respect our Planet, Care for People, and Trusted Business – and highlights the continued integration of sustainability into all aspects of its operations. “Our business is built on extending the life of existing flo...